Advertisement

Agents and Actions

, Volume 6, Issue 1–3, pp 211–218 | Cite as

Immunological and non-immunological mechanisms of some of the desirable and undesirable effects of anti-inflammatory and analgesic drugs

  • E. S. K. Assem
Symposium 4 General Aspects of Inflammation I

Abstract

Studies were carried out on patients with adverse reactions to aspirin, paracetamol, phenacetin, codeine, dihydrocodeine, some pyrazolone derivatives, and indomethacin. Three clinico-pathological forms of adverse reactions received particular attention: (1) Asthma, with or without manifestations of systemic anaphylaxis; (2) Serum-sicknesslike syndrome; (3) Lymph node enlargement with histological features simulating lymphoma or Hodgkin's disease, which occurred in patients receiving phenylbutazone in particular. A variety of immunological investigations, including some in vitro correlates of immediate- or delayed-type allergy, were carried out. The three syndromes seemed to be associated with immediate-type (or immediate-type-like), immediate-type plus delayed-type, and delayed-type allergy, respectively. In most of the patients with immediate-type-like reactions, and where immunological mechanisms were apparently not involved, pharmacological mediators, particularly histamine, were released from their leucocytes when challenged in vitro with the causative agent(s). This suggested that the main underlying abnormality of their asthma of peripheral vascular manifestations was a direct release of mediators by the drugs, i.e. some type of idiosyncrasy. The causative mechanism of this abnormality has not been established yet.

Keywords

Asthma Aspirin Histamine Indomethacin Paracetamol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Assem, E.S.K., and McAllen, M.K.,Serum reagins and leucocyte response in patients with house dust mite allergy, Br. Med. J.ii, 504–507 (1970).Google Scholar
  2. [2]
    Assem, E.S.K., and Richter, A.W.,Comparision of in vivo and in vitro inhibition of the anaphylactic mecanism by B-adrenergic stimulants and disodium cromoglycate. Immunology21, 729–739 (1971).PubMedGoogle Scholar
  3. [3]
    Assem, E.S.V., and Schild, H.O.,Anti-anaphylactic effect of catecholamines, Ciênc. Cult.23, 551–553 (1971).Google Scholar
  4. [4]
    Chalmers, D.G., Cooper, E.H., Evans, C., and Topping, N.E.,Quantitation of the response of lymphocytes in culture to specific and non specific stimulation, Int. Arch. Allergy32, 117–130 (1967).PubMedGoogle Scholar
  5. [5]
    Collier, H.O.J., Adv. Pharmac. Chemother.7, 333 (1969).Google Scholar
  6. [6]
    Collier, H.O.J.,Prostaglandins and aspirin Nature232, 17–19 (1971).PubMedGoogle Scholar
  7. [7]
    Collier, H.O.J., and Sweatman, W.J.F.,Antagonism by fenamates of prostaglandin F and slow reacting substance on human bronchial muscle, Nature219, 864–865 (1968).Google Scholar
  8. [8]
    Dawson, W., Lewis, R.L., McMahon, R.E., and Sweatman, W.J.F.,Potent broncho constrictor activity of 15 Keto prostaglandin F , Nature250, 331–332 (1974a).PubMedGoogle Scholar
  9. [9]
    Dawson, W., Sweatman, W.J.F., Brockwell, A.D.J., and Boot, J.R.,Pharmacological studies on SRS-A and PG release from immunologically challenged human and guinea-pig lung abstrasts, 9th European Academy of Allerlology and Clinical Immunology, London, p. 56 (1974b).Google Scholar
  10. [10]
    Grubb, M.N., and Burks, T.F.,Selective antagonism of the stimulatory effects of morphine by isoproterenol, prostaglandin E 1 and theophylline, J. Pharmac. exp. Ther.193, 884–891 (1975).Google Scholar
  11. [11]
    Herxheimer, H., and Stresemann, E.,Anti-asthmatic effect of phenazone and amidopyrine, Nature192, 1089 (1961).Google Scholar
  12. [12]
    James, G.W.L.,The use of the in vivo trachea preparation of the guinea-pig to assess drug action on lung, J. Pharm. Pharmac.21, 37–386 (1969).Google Scholar
  13. [13]
    Littlejohns, D.W., Assem, E.S.K., and Kennedy, C.T.C.,Immunological evidence of two forms of allergy to pyrazolone drugs. Rheumatol. Rehab.XII, 57–61 (1973).Google Scholar
  14. [14]
    Mathé, A.A., Hedqvist, P., Holmgren, A., and Svanborg, N.,Hypersensitivity to prostaglandin F and histamine in patients with asthma, Br. Med. J.i, 193–196 (1973).Google Scholar
  15. [15]
    Paton, W.D.M.,Histamine release by compounds of simple chemical structure, Pharmac. Rev.9, 269–328 (1957).Google Scholar
  16. [16]
    Piper, P.J., and Vane, J.R.,Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs, Nature223, 29–35 (1969).PubMedGoogle Scholar
  17. [17]
    Samter, M., and Beers, R.F., Jr.,Intolerance to aspirin. Clinical studies and consideration of its pathogenesis, Ann. int. Med.68, 975–983 (1968).PubMedGoogle Scholar
  18. [18]
    Smith, J.B., and Willis, A.L.L.,Aspirin selectively inhibits prostaglandin production in human platelets, Nature New Biol.231, 235–237 (1971).PubMedGoogle Scholar
  19. [19]
    Stevenson, A.C.,Chromosomal studies in patients taking phenylbutazone, Ann. Rheum. Dis.30, 487–500 (1971).PubMedGoogle Scholar
  20. [20]
    Stresemann, E.,Die Wirkung von antipyretischen Substanzen auf das menschliche Bronchialasthma und das experimentelle Meerschweinchenasthma, Acta Allergy18, 211 (1963).Google Scholar
  21. [21]
    Szczekelik, A., Gryglewski and Czerniawska, Mysik,Relationship of inhibition of prostaglandin biosynthesis by analge to asthma attacks in aspirin sensitive patients, Br. Med. J.i, 67–69 (1975).Google Scholar
  22. [22]
    Vane, J.R.,Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs, Nature New Biol.231, 232–235 (1971).PubMedGoogle Scholar
  23. [23]
    Winter, C.A.,Anti-inflammatory testing methods: comparative evaluation of indomethacin and other agents, in: Garatini, S., and Dukes, M.N.G.,Anti-inflammatory drugs (Exerpta Medica, Amsterman 1964), p. 190–202.Google Scholar
  24. [24]
    Yurchak, A.M., Wicher, K., and Arbesman, C.E.,Immunologic studies on aspirin: Clinical studies with aspiryl conjugates, J. Allergy46, 245–253 (1970).PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1976

Authors and Affiliations

  • E. S. K. Assem
    • 1
  1. 1.Department of PharmacologyUniversity CollegeLondon

Personalised recommendations